One year later, European public health experts question WHO Level 6 H1N1 declaration

The issue is how much influence did pharmaceutical companies have in the WHO decision to ratchet up H1N1 to Level 6. A feature article in the British Medical Journal mirrors the tone of the controversy.

"A joint investigation by the BMJ and the Bureau of Investigative Journalism has uncovered evidence that raises troubling questions about how WHO managed conflicts of interest among the scientists who advised its pandemic planning, and about the transparency of the science underlying its advice to governments. "

I will do my best to post more information as time allows. The link takes up where I've left off.

 

http://www.bmj.com/cgi/content/full/340/jun03_4/c2912

Tags: British_Medical_Journal, CDC, Deborah_Cohen, H1N1, Margaret_Chan, Phillip_Carter, WHO, conflict_of_interest, influenza, influenza_mortality, More…pandemic, pharmaceutical_companies, public_health, swine_flu, vaccine

Views: 4

© 2013   Created by Dialogue4Health.

Badges  |  Contact Us  |  Terms of Service